Inventor · disambiguated record
Craig A. Smith
Also filed as: SMITH CRAIG · SMITH CRAIG A · SMITH CRAIG ALLEN
34 granted patents·15 pending applications·2,870 citations·filing 1990–2013
98Inventor score
Files withIMMUNEX CORP30CARDIOGENESIS CORP3VIRAL LOGIC SYSTEMS TECHNOLOGY3DORAN TIMOTHY JAMES2GOODWIN RAYMOND G2
Top patents by PatentIndex Score
49 records- 0198US6572852B2Method for suppressing inflammatory responses by administering TNFRIMMUNEX CORP·Filed 2001·Granted Jun 3, 2003·83 cites·8 claims
- 0297US5480981ACD30 ligandIMMUNEX CORP·Filed 1994·Granted Jan 2, 1996·259 cites·20 claims
- 0397US5395760ADNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1990·Granted Mar 7, 1995·259 cites·20 claims
- 0496US6355779B1Cytokine designated 4-1BB ligand antibodies and human receptor that binds theretoIMMUNEX CORP·Filed 1998·Granted Mar 12, 2002·166 cites·4 claims
- 0596US5605690AMethods of lowering active TNF-α levels in mammals using tumor necrosis factor receptorIMMUNEX CORP·Filed 1995·Granted Feb 25, 1997·527 cites·6 claims
- 0695US6224584B1Therapeutic and diagnostic agent deliveryECLIPSE SURGICAL TECH·Filed 1999·Granted May 1, 2001·165 cites·8 claims
- 0795US5712155ADNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1994·Granted Jan 27, 1998·90 cites·17 claims
- 0894US8377448B2CD47 related compositions and methods for treating immunological diseases and disordersUNIV LELAND STANFORD JUNIOR·Filed 2010·Granted Feb 19, 2013·28 cites·6 claims
- 0994US6541610B1Fusion proteins comprising tumor necrosis factor receptorIMMUNEX CORP·Filed 1995·Granted Apr 1, 2003·103 cites·30 claims
- 1094US6201105B1Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)Filed 1999·Granted Mar 13, 2001·77 cites·4 claims
- 1193US5674704ACytokine designated 4-IBB ligandIMMUNEX CORP·Filed 1994·Granted Oct 7, 1997·123 cites·20 claims
- 1292USRE36755EDNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1998·Granted Jun 27, 2000·94 cites·1 claims
- 1392US5840059ATherapeutic and diagnostic agent deliveryCARDIOGENESIS CORP·Filed 1995·Granted Nov 24, 1998·324 cites·7 claims
- 1489US7138500B1Antibodies to human 4-1BBIMMUNEX CORP·Filed 1998·Granted Nov 21, 2006·50 cites·6 claims
- 1585US7057022B2Antibodies which specifically bind to TNF-RIMMUNEX CORP·Filed 2003·Granted Jun 6, 2006·13 cites·16 claims
- 1684US5997525ATherapeutic and diagnostic agent deliveryCARDIOGENESIS CORP·Filed 1998·Granted Dec 7, 1999·179 cites·8 claims
- 1783US7875718B2Process for the synthesis of morphinane compounds and intermediates thereofJOHNSON MATTHEY PLC·Filed 2007·Granted Jan 25, 2011·7 cites·31 claims
- 1883US7459528B2Glycoproteins which bind to TNFIMMUNEX CORP·Filed 2005·Granted Dec 2, 2008·3 cites·30 claims
- 1983US6667039B1CD30 ligandIMMUNEX CORP·Filed 2000·Granted Dec 23, 2003·5 cites·32 claims
- 2083US5677430AAntibodies directed against CD30 ligandIMMUNEX CORP·Filed 1995·Granted Oct 14, 1997·28 cites·6 claims
- 2182US5589456AGranulocyte-colony stimulating factor receptorsIMMUNEX CORP·Filed 1995·Granted Dec 31, 1996·38 cites·2 claims
- 2280US5945397APurified p75 (type II) tumor necrosis factor receptor polypeptidesIMMUNEX CORP·Filed 1996·Granted Aug 31, 1999·52 cites·52 claims
- 2380US5871740AMethods of using poxvirus p35 as a chemokine inhibitor and compositions thereforeIMMUNEX CORP·Filed 1996·Granted Feb 16, 1999·44 cites·29 claims
- 2480US5464938AIsolated viral protein TNF antagonistsIMMUNEX CORP·Filed 1994·Granted Nov 7, 1995·54 cites·6 claims
- 2579US8293500B2Methods for identifying polypeptide targets and uses thereof for treating immunological diseasesWILEY STEVEN·Filed 2007·Granted Oct 23, 2012·7 cites·38 claims
- 2679US6143869ACD30 ligand oligomers and polypeptidesIMMUNEX CORP·Filed 1998·Granted Nov 7, 2000·21 cites·8 claims
- 2775US6852486B2Viral proteins capable of binding LARIMMUNEX CORP·Filed 2002·Granted Feb 8, 2005·6 cites·10 claims
- 2875US5422248ADNA sequences encoding granulocyte-colony stimulating factor receptorsIMMUNEX CORP·Filed 1993·Granted Jun 6, 1995·34 cites·16 claims
- 2968US7232660B2CD30 ligandIMMUNEX CORP·Filed 2003·Granted Jun 19, 2007·0 cites·13 claims
- 3066US2009264349A1CD30 LigandIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 3161US7211259B14-1BB polypeptides and DNA encoding 4-1BB polypeptidesIMMUNEX CORP·Filed 1997·Granted May 1, 2007·9 cites·19 claims
- 3260US5359039AIsolated poxvirus A53R-equivalent tumor necrosis factor antagonistsIMMUNEX CORP·Filed 1993·Granted Oct 25, 1994·15 cites·2 claims
- 3360US2009270592A1Purified TNFR preparationsIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 3457US2003082736A1Fusion proteins comprising tumor necrosis factor receptorIMMUNEX CORP·Filed 2002·Application pending·0 cites
- 3556US5753203ACD30 ligand conjugatesIMMUNEX CORP·Filed 1995·Granted May 19, 1998·5 cites·16 claims
- 3656US2006110802A1Cytokine designated 4-1BB ligand and human receptor that binds theretoGOODWIN RAYMOND G·Filed 2003·Application pending·0 cites
- 3756US2009117112A1Immunomodulatory compositions and uses thereforVIRAL LOGIC SYSTEMS TECHNOLOGY·Filed 2008·Application pending·0 cites
- 3855US2006275868A1Fusion proteins comprising tumor necrosis factor receptorIMMUNEX CORP·Filed 2006·Application pending·0 cites
- 3955US2005176640A1Viral proteins capable of binding LARIMMUNEX CORP·Filed 2004·Application pending·0 cites
- 4051US2007134234A1Immunomodulatory compositions and uses thereforVIRAL LOGIC SYSTEMS TECHNOLOGY·Filed 2006·Application pending·0 cites
- 4149US6524298B1Therapeutic and diagnostic agent deliveryCARDIOGENESIS CORP·Filed 2001·Granted Feb 25, 2003·2 cites·9 claims
- 4249US2012227119A1Methods of Modulating the Sex of AviansDORAN TIMOTHY JAMES·Filed 2009·Application pending·0 cites
- 4349US2006127985A1Cytokine designated 4-1BB ligand and human receptor that binds theretoGOODWIN RAYMOND G·Filed 2005·Application pending·0 cites
- 4448US8106201B2Process for the synthesis of morphinane compounds and intermediates thereofSMITH CRAIG·Filed 2011·Granted Jan 31, 2012·0 cites·8 claims
- 4548US2013067606A1Modulating production traits in aviansDORAN TIMOTHY JAMES·Filed 2012·Application pending·0 cites
- 4644US2008131431A1CD47 related compositions and methods for treating immunological diseases and disordersVIRAL LOGIC SYSTEMS TECHNOLOGY·Filed 2007·Application pending·0 cites
- 4743US2013129748A1Methods for identifying polypeptide targets and uses thereof for treating immunological diseasesWILEY STEVEN·Filed 2012·Application pending·0 cites
- 4840US2012084873A1Sex-determination and methods of specifying sameSINCLAIR ANDREW·Filed 2010·Application pending·0 cites
- 4939US2014066595A1Modulators of Protein Production in a Human Cell Line and Cell-free Extracts Produced TherefromANDERSON EMILY·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Craig A. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →